This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A slow but sure approach to governance can keep AI champions focused on improving patient care when—and even after—the technology builds unstoppable momentum seemingly of its own accord.
Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.
The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.
What good is AI in healthcare if it doesn’t improve financial margins? The question is getting posed in the C-suites of provider organizations and insurance companies.
SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals.
SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more.
The new collaboration aims to enable providers to provide hospital-level care at home, leaning on Atrium Health’s telemedicine services and Best Buy Health’s ongoing care at home platform.
The United States has some of the best hospitals in the world, including the No. 1 overall best hospital, according to a recent ranking of hospitals by Newsweek.
Also, researchers noted, cryoballoon ablation was linked to a lower risk of cardiac tamponade than radiofrequency ablation. The study included data from nearly 60,000 hospitalizations.